Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Siemens became aware of an error in the pressure/temperature compensation for dose monitor 2 for electron treatments. only digital linear accelerators (linac) running control console software version 12 or 13 are affected. this error may result in a higher deviation of the dose rate in electron mode than specified. the dose monitor 1 controls the overall dose monitoring system and remains unaffected. the actual dose rate and the accumulated monitor units and thus the absolute dose are correctly displayed at the linac console.